Cancer Research  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 55, 1491-1498, April 1, 1995]
© 1995 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Streeper, R. T.
Right arrow Articles by Colvin, O. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Streeper, R. T.
Right arrow Articles by Colvin, O. M.

Molecular Pharmacology of Hepsulfam, NSC 3296801: Identification of Alkylated Nucleosides, Alkylation Site, and Site of DNA Cross-Linking1

Robert T. Streeper, Robert J. Cotter, Michael E. Colvin, John Hilton and O. Michael Colvin2

Department of Pharmacology and Molecular Sciences [R. T. P., R. J. C., O. M. C.] and Oncology Center [J. H., O. M. C.], The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, and the Center for Computational Engineering, Sandia National Laboratories, Livermore, California 94551 [M. E. C.]

We have determined that hepsulfam, in common with its structural homologue busulfan, alkylates both free guanosine and GMP in DNA at the 7 nitrogen. Mass spectral analysis of the products of the reaction of hepsulfam with guanosine has identified the mono- and bis-alkylated guanosine adducts. UV spectrophotometry and mass spectrometry were used to confirm that alkylation occurred at the 7 nitrogen by following the formation of the formamidopyrimidyl form of the hepsulfam-guanosine adduct at high pH. We have also isolated and identified 1-guanyl,7-hydroxyheptane, 1-guanyl,7-sulfamylheptane, and 1,7-bis(guanyl)heptane from in vitro reaction mixtures of hepsulfam and calf thymus DNA. We have isolated bis-(7-formamidopyrimidyldeoxyguanosinyl)-heptane from an enzymatic digest of DNA treated with hepsulfam. Finally, we have found that hepsulfam forms interstrand cross-links at 5'-GXC-3' sites in model oligonucleotides.

1 These studies were supported by by USPHS Training Grant CA09243 14 (R. T. S.), NIH-National Cancer Institute Grants 2RO1CA16783-1 and 5P01CA15396-19 (O. M. C.), and by National Science Foundation Grant DIR 90-16567 (R. J. C.). Mass spectra were obtained in the Middle Atlantic Mass Spectrometry Laboratory, a National Science Foundation Shared Instrument Facility.

2 To whom requests for reprints should be addressed, at The Johns Hopkins Oncology Center, 600 North Wolfe Street, Oncology 1-121, Baltimore, MD 21287-8934.

Received 11/15/94. Accepted 2/ 3/95.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1995 by the American Association for Cancer Research.